The efficacy of axitinib as a first-line treatment for metastatic renal cell carcinoma.
Kameda T, Takayama T, Sugihara T, Takeshima S, Yamazaki M, Komatsubara M, Kamei J, Fujisaki A, Ando S, Kurokawa S, Fujimura T.
Kameda T, et al. Among authors: kurokawa s.
Asia Pac J Clin Oncol. 2020 Aug;16(4):241-246. doi: 10.1111/ajco.13323. Epub 2020 Mar 4.
Asia Pac J Clin Oncol. 2020.
PMID: 32129940